199 related articles for article (PubMed ID: 28336941)
21. Propranolol therapy for infantile hemangioma: our experience.
Zhang L; Wu HW; Yuan W; Zheng JW
Drug Des Devel Ther; 2017; 11():1401-1408. PubMed ID: 28507428
[TBL] [Abstract][Full Text] [Related]
22. Successful discontinuation of propranolol for infantile hemangiomas of the head and neck at 12 months of age.
Hong P; Tammareddi N; Walvekar R; Chiu ES; Poole JC; Kluka EA; Simon LM
Int J Pediatr Otorhinolaryngol; 2013 Jul; 77(7):1194-7. PubMed ID: 23706952
[TBL] [Abstract][Full Text] [Related]
23. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes.
Park M; Jung HL; Shim YJ; Kim HS; Yoon HS; Park SK; Cheuh HW; Lee MJ; Lee JM; Park ES; Lee JH; Lim YJ; Choi YB
Pediatr Res; 2020 Nov; 88(5):749-755. PubMed ID: 32311699
[TBL] [Abstract][Full Text] [Related]
24. Oral propranolol for the treatment of infantile haemangiomas in Singapore.
Tan JMC; Lim HW; Koh MJ
Singapore Med J; 2021 Mar; 62(3):139-142. PubMed ID: 31989180
[TBL] [Abstract][Full Text] [Related]
25. Multiple pulmonary infantile hemangiomas responsive to oral propranolol.
Galdeano F; Herón A; Moreno S; Aprea G; Meneses M; Torrelo A
Pediatr Dermatol; 2021 Jan; 38(1):226-228. PubMed ID: 33155718
[TBL] [Abstract][Full Text] [Related]
26. Propranolol treatment of infantile hemangioma: clinical and radiologic evaluations.
Talaat AA; Elbasiouny MS; Elgendy DS; Elwakil TF
J Pediatr Surg; 2012 Apr; 47(4):707-14. PubMed ID: 22498385
[TBL] [Abstract][Full Text] [Related]
27. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action.
Storch CH; Hoeger PH
Br J Dermatol; 2010 Aug; 163(2):269-74. PubMed ID: 20456345
[TBL] [Abstract][Full Text] [Related]
28. Low-dose propranolol for infantile hemangioma of the head and neck: Analysis of 23 consecutive patients.
Ren W; Li S; Gao L; Huang S; Zhang L; Qiang C; Liu C; Zhi K
Pediatr Int; 2017 Feb; 59(2):213-217. PubMed ID: 27473874
[TBL] [Abstract][Full Text] [Related]
29. Propranolol and infantile hemangiomas four years later: a systematic review.
Marqueling AL; Oza V; Frieden IJ; Puttgen KB
Pediatr Dermatol; 2013; 30(2):182-91. PubMed ID: 23405852
[TBL] [Abstract][Full Text] [Related]
30. Propranolol as an effective therapy for infantile haemangioma of the urinary bladder.
Anwar T; Malm-Buatsi E
BMJ Case Rep; 2019 Feb; 12(2):. PubMed ID: 30709884
[TBL] [Abstract][Full Text] [Related]
31. Propranolol in the management of periorbital infantile haemangioma.
Cheng JF; Gole GA; Sullivan TJ
Clin Exp Ophthalmol; 2010 Aug; 38(6):547-53. PubMed ID: 20553300
[TBL] [Abstract][Full Text] [Related]
32. When to stop propranolol for infantile hemangioma.
Chang L; Gu Y; Yu Z; Ying H; Qiu Y; Ma G; Chen H; Jin Y; Lin X
Sci Rep; 2017 Feb; 7():43292. PubMed ID: 28225076
[TBL] [Abstract][Full Text] [Related]
33. Shouldn't Propranolol Be Used to Treat All Haemangiomas?
Moodley ST; Hudson DA; Adams S; Adams KG
Aesthetic Plast Surg; 2015 Dec; 39(6):963-7. PubMed ID: 26377820
[TBL] [Abstract][Full Text] [Related]
34. Outpatient treatment of infantile hemangiomas with propranolol: a prospective study.
Betlloch-Mas I; Martínez-Miravete MT; Lucas-Costa A; Martin de Lara AI; Selva-Otalaurruchi J
Actas Dermosifiliogr; 2012 Nov; 103(9):806-15. PubMed ID: 22727954
[TBL] [Abstract][Full Text] [Related]
35. Teledermatology in paediatrics: Health-care impact on the early treatment of infantile haemangiomas.
Betlloch-Mas I; Martínez-Miravete MT; Berbegal-DeGracia L; Sánchez-Vázquez L; Sánchez-Payá J
J Telemed Telecare; 2021 Aug; 27(7):424-430. PubMed ID: 32188311
[TBL] [Abstract][Full Text] [Related]
36. Treatment of severe infantile hemangiomas with propranolol: an evaluation of the efficacy and effects of cardiovascular parameters in 25 consecutive patients.
Xu DP; Cao RY; Xue L; Sun NN; Tong S; Wang XK
J Oral Maxillofac Surg; 2015 Mar; 73(3):430-6. PubMed ID: 25544304
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of propranolol in the treatment of infantile hemangioma beyond the proliferation phase.
Vivas-Colmenares GV; Bernabeu-Wittel J; Alonso-Arroyo V; Matute de Cardenas JA; Fernandez-Pineda I
Pediatr Dermatol; 2015; 32(3):348-52. PubMed ID: 25721095
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of infantile haemangiomas of the orbit with propranolol.
Li YC; McCahon E; Rowe NA; Martin PA; Wilcsek GA; Martin FJ
Clin Exp Ophthalmol; 2010 Aug; 38(6):554-9. PubMed ID: 20491798
[TBL] [Abstract][Full Text] [Related]
39. The use of propranolol in the management of periocular capillary haemangioma--a systematic review.
Spiteri Cornish K; Reddy AR
Eye (Lond); 2011 Oct; 25(10):1277-83. PubMed ID: 21738233
[TBL] [Abstract][Full Text] [Related]
40. Failure of propranolol in the treatment of childhood haemangiomas of the head and neck.
Goswamy J; Rothera MP; Bruce IA
J Laryngol Otol; 2011 Nov; 125(11):1164-72. PubMed ID: 21846414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
